These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27005869)

  • 21. Detection of human herpesvirus 6 (HHV-6) and human herpesvirus 7 (HHV-7) DNA in endocervical samples from a positive and negative HPV woman of Córdoba, Argentina.
    Biganzoli P; Frutos MC; Venezuela F; Mosmann J; Kiguen A; Pavan J; Ferreyra L; Cuffini C
    J Clin Pathol; 2020 Jan; 73(1):30-34. PubMed ID: 31315894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relevance of the Pap Test: A Report of HPV-DNA Test-Negative High-Grade Squamous Intraepithelial Lesions of the Female Lower Genital Tract.
    Hui Y; Hansen K; Murthy J; Chau D; Sung CJ; Quddus MR
    Acta Cytol; 2016; 60(5):445-450. PubMed ID: 27578366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do Infection Patterns of Human Papillomavirus Affect the Cytologic Detection of High-Grade Cervical Lesions on Papanicolaou Tests?
    Samimi SA; Mody RR; Goodman S; Luna E; Armylagos D; Schwartz MR; Mody DR; Ge Y
    Arch Pathol Lab Med; 2018 Mar; 142(3):347-352. PubMed ID: 29160722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G; Yang B; Abdul-Karim FW
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression.
    Gimenes F; Souza RP; de Abreu AL; Pereira MW; Consolaro ME; da Silva VR
    Arch Gynecol Obstet; 2016 Apr; 293(4):857-63. PubMed ID: 26315473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of HPV testing on cervical cancer screening].
    Li G
    Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):241-5. PubMed ID: 26080933
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
    Gu L; Hong Z; Gao H; Qiu L; Di W
    Cytopathology; 2019 Jul; 30(4):419-425. PubMed ID: 31069857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
    Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
    J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
    Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN
    Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification of specific chromosomal regions assessed by fluorescent in situ hybridization on Pap smears to be added as screening tool for identifying women at risk of progressing to cervical cancer.
    Upendram P; Sahni S; Mohiuddin K; Poornima S; Gourishankar B; Kumar Vattam K; Boddala P; Jayashankar E; Mohiuddin S; Kamineni V; Mohan V; Houldsworth J; Hasan Q
    Tumour Biol; 2017 Oct; 39(10):1010428317698363. PubMed ID: 28990460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical and methylation status of human papillomavirus 16 in asymptomatic cervical infections changes with malignant transformation.
    Dutta S; Chakraborty C; Dutta AK; Mandal RK; Roychoudhury S; Basu P; Panda CK
    J Clin Pathol; 2015 Mar; 68(3):206-11. PubMed ID: 25563334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of HPV 16/18 Genotyping and p16/Ki-67 Dual Staining to Predict Progression to HSIL/CIN2+ in Negative Cytologies From a Colposcopy Referral Population.
    Rodríguez-Trujillo A; Martí C; Angeles MA; Sierra A; Esteve R; Saco A; Barnadas E; Marimón L; Nicolás I; Torné A; Ordi J; Del Pino M
    Am J Clin Pathol; 2018 Oct; 150(5):432-440. PubMed ID: 30052715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological Investigation and Risk Factors for Cervical Lesions: Cervical Cancer Screening Among Women in Rural Areas of Henan Province China.
    Zhang Q; Xie W; Wang F; Li RH; Cui L; Wang H; Fu X; Song J
    Med Sci Monit; 2016 Jun; 22():1858-65. PubMed ID: 27249229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2012 cervical cancer screening guidelines and the future role of HPV testing.
    Priebe AM
    Clin Obstet Gynecol; 2013 Mar; 56(1):44-50. PubMed ID: 23337843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
    Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
    Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer awareness and presence of abnormal cytology among HIV-infected women on antiretroviral therapy in rural Andhra Pradesh, India.
    Shin SS; Carpenter CL; Ekstrand ML; Wang Q; Grover S; Zetola NM; Yadav K; Sinha S; Nyamathi AM
    Int J STD AIDS; 2019 May; 30(6):586-595. PubMed ID: 30813859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women.
    Sharma S; Hussain S; Soni K; Singhal P; Tripathi R; Ramachandran VG; Sharma S; Das S; Pillai B; Bharadwaj M
    Tumour Biol; 2016 Apr; 37(4):4585-95. PubMed ID: 26508022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV home tests could spot cancer risk.
    Br Dent J; 2014 Feb; 216(3):101. PubMed ID: 24504278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.